- Home
- SOS vs XAIR Comparison
SOS vs XAIR Comparison
Compare SOS & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOS | XAIR |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 10.1M |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SOS | XAIR |
|---|---|---|
| Price | $1.00 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 181.7K | 137.8K |
| Earning Date | 05-14-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.09 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,705,000.00 |
| Revenue This Year | N/A | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 219.67 |
| 52 Week Low | $0.92 | $0.15 |
| 52 Week High | $8.92 | $3.78 |
Technical Indicators
Market Signals| Indicator | SOS | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 34.88 | 31.20 |
| Support Level | N/A | $0.67 |
| Resistance Level | $1.92 | $1.25 |
| Average True Range (ATR) | 0.21 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 6.82 | 3.79 |
Price Performance
Historical ComparisonAbout SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.